Vitamins for Prevention of Contrast-induced Acute Kidney Injury: A Systematic Review and Trial Sequential Analysis
- 64 Downloads
To date, universally accepted preventive measures for contrast-induced acute kidney injury (CI-AKI) do not exist, and they warrant further research.
The purpose of this study was to evaluate the efficacy of vitamins, including vitamin C and E, for prevention of CI-AKI.
We electronically searched the MEDLINE, EMBASE, and Cochrane databases. The outcome of interest was the incidence of CI-AKI.
A total of 19 studies were included in this meta-analysis. Pooled analysis showed that vitamin C plus saline [relative risk (RR) = 0.63, 95% confidence interval (CI) 0.49–0.82, p = 0.0005] and vitamin E plus saline (RR = 0.39, 95% CI 0.24–0.62, p < 0.0001) significantly reduced the incidence of CI-AKI compared to saline alone. The effect of vitamin C plus saline was further confirmed by trial sequential analysis (TSA). However, TSA indicated that more trials are required to confirm the efficacy of vitamin E plus saline. There was no significant difference in preventing CI-AKI between vitamin C and N-acetylcysteine (NAC) (RR = 0.90, 95% CI 0.47–1.71, p = 0.75), between vitamin C plus NAC and saline (RR = 0.62, 95% CI 0.30–1.30, p = 0.20), as well as between vitamin C plus NAC and NAC (RR = 0.97, 95% CI 0.49–1.92, p = 0.93).
Vitamin C plus saline administration is effective at reducing the risk of CI-AKI. Evidence for the use of vitamin E plus saline in this context is encouraging, but more trials are required. Furthermore, this meta-analysis and TSA indicated insufficient power to draw a definitive conclusion on the effect of vitamin C plus NAC, versus saline or NAC alone, which needs to be explored further.
The English in this document has been checked by at least two professional editors, both native speakers of English, from Textcheck Scientific and Technical Editing Service.
Research idea and study design: YX, JG, XZ; data acquisition: ZG, JG; data analysis/interpretation: ZG, JG, YX; statistical analysis: YX; the writing of the paper: ZG, XZ, BL; supervision or mentorship: JG, YX.
Compliance with Ethical Standards
This study was supported in part by Hainan Natural Science Foundation of China to Z.Y.G (No.20168350) and Sanya Medical and Health Science and Technology Innovation Project of China to Z.Y.G (No. 2015YW24).
Conflict of Interest
Yongxing Xu, Xinming Zheng, Boran Liang, Jianjun Gao and Zhaoyan Gu declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. Informed consent was not involved.
- 8.Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. J Interv Cardiol. 2013;26(1):90–6.CrossRefPubMedGoogle Scholar
- 10.Ali-Hasan-Al-Saegh S, Mirhosseini SJ, Ghodratipour Z, Sarrafan-Chaharsoughi Z, Rahimizadeh E, Karimi-Bondarabadi AA, et al. Strategies preventing contrast-induced nephropathy after coronary angiography: a comprehensive meta-analysis and systematic review of 125 randomized controlled trials. Angiology. 2017;68(5):389–413.CrossRefPubMedGoogle Scholar
- 11.Giacoppo D, Gargiulo G, Buccheri S, Aruta P, Byrne RA, Cassese S, et al. Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: evidence from a hierarchical Bayesian network meta-analysis of 124 trials and 28 240 patients. Circ Cardiovasc Interv. 2017;10(5):e004383.CrossRefPubMedGoogle Scholar
- 13.Brueck M, Cengiz H, Hoeltgen R, Wieczorek M, Boedeker RH, Scheibelhut C, et al. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial. J Invasive Cardiol. 2013;25(6):276–83.PubMedGoogle Scholar
- 16.Ali-Hasan-Al-Saegh S, Mirhosseini SJ, Ghodratipour Z, Sarafan-Chaharsoughi Z, Dehghan AM, Rahimizadeh E, et al. Protective effects of anti-oxidant supplementations on contrast-induced nephropathy after coronary angiography: an updated and comprehensive meta-analysis and systematic review. Kardiol Pol. 2016;74(7):610–26.CrossRefPubMedGoogle Scholar
- 18.Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive–trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2009;38(1):287–98.CrossRefPubMedGoogle Scholar
- 28.Roshanov PS, Dennis BB, Pasic N, Garg AX, Walsh M. When is a meta-analysis conclusive? A guide to trial sequential analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery. Nephrol Dial Transplant. 2017;32(suppl 2):ii23–30.CrossRefPubMedGoogle Scholar
- 31.El-Fishawy HSN, Soliman A. Ascorbic acid and acetylcysteine for prevention of acute deterioration of renal function following elective aorto-iliac and coronary angioplasty. NDT Plus. 2010;3:300.Google Scholar
- 32.Grygier MJM, Araszkiewicz A, Kowal J, Mularek-Kubzdela T, Olasinska-Wisniewska A, Seniuk W, Popiel M, Lesiak M, Grajek S. Combined treatment with ascorbic acid and N-acetylcysteine prevents contrast-induced nephropathy in high-risk patients with acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J. 2011;32:954–5.Google Scholar
- 33.Habib M, Hillis A, Hammad A. N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: the NAPCIN trial; A single-center, prospective, randomized trial. Saudi J Kidney Dis Transpl. 2016;27(1):55–61.CrossRefPubMedGoogle Scholar
- 34.Hamdi SSW, Hraiech A, Jomaa W, Hamda KB, Maatouk F. Prevention of contrast induced nephropathy in patients undergoing coronarography with ascorbic acid. JACC. 2013;1:S22.Google Scholar
- 35.Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, et al. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study—a prospective randomized controlled trial. Am Heart J. 2009;157(3):576–83.CrossRefPubMedGoogle Scholar
- 38.Rezaei Y, Khademvatani K, Rahimi B, Khoshfetrat M, Arjmand N, Seyyed-Mohammadzad MH. Short-term high-dose vitamin E to prevent contrast medium-induced acute kidney injury in patients with chronic kidney disease undergoing elective coronary angiography: a randomized placebo-controlled trial. J Am Heart Assoc. 2016;5(3):e002919.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.Kitzler TM, Jaberi A, Sendlhofer G, Rehak P, Binder C, Petnehazy E, et al. Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. Wien Klin Wochenschr. 2012;124(9–10):312–9.CrossRefPubMedGoogle Scholar
- 44.Addad F, Triki M, Ibn El Hadj Z, Laaroussi L, Marrakchi S, Ben Amara W, et al. Does oral ascorbic acid plus sodium bicarbonate protect against contrast-induced nephropathy in diabetic and/or renal insufficiency patients undergoing coronary angiography? A multicentre randomised controlled trial. EuroIntervention, EuroPCR Abstracts and Posters 2014.Google Scholar
- 45.Shakeryan F, Sanati H, Fathi H, Firouzi A, Zahedmehr A, Valizadeh G, et al. Evaluation of combination therapy with vitamin C and pentoxifylline on preventing kidney failure secondary to intravenous contrast material in coronary angioplasty. Iran Heart J. 2013;14(3):17–21.Google Scholar